BIM-23190 is a synthetic peptide analog used to probe receptor-specific binding and conformational changes within targeted signaling pathways. The sequence contains hydrophobic and charged residues influencing secondary structure. Researchers employ it to dissect ligand architecture and binding kinetics. Its stability supports extensive biophysical evaluation.
CAT No: PI-008
CAS No:182153-96-4
Synonyms/Alias:BIM-23190;182153-96-4;BIM 23190;V55PUY46VR;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-7-ethyl-19-[[(2R)-2-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]acetyl]amino]-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;L-THREONINAMIDE, N-(2-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)ACETYL)-D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-(2S)-2-AMINOBUTANOYL-L-CYSTEINYL-, CYCLIC (2->7)-DISULFIDE;BDBM85051;HY-P3124;CS-0146506;L-Threoninamide, N-((4-(2-hydroxyethyl)-1-piperazinyl)acetyl)-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-(2S)-2-aminobutanoyl-L-cysteinyl-, cyclic (2-7)-disulfide;L-Threoninamide, N-((4-(2-hydroxyethyl)-1-piperazinyl)acetyl)-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-2-aminobutanoyl-L-cysteinyl-, cyclic (2-7)-disulfide;L-Threoninamide, N-[2-[4-(2-hydroxyethyl)-1-piperazinyl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-(2S)-2-aminobutanoyl-L-cysteinyl-, cyclic (2-->7)-disulfide;N-(N'-(2-hydroxyethyl)-piperazinyl)-2-acetyl-Phe-Cys-Tyr-Trp-Lys-Abu-Cys-Thr-NH2 disulfide;N-(N'-(2-hydroxyethyl)piperazinyl)-2-acetyl-phenylalanyl-cysteinyl-tyrosyl-tryptophyl-lysyl-2-aminobutanoyl-cysteinyl-threoninamide disulfide;
Chemical Name:(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-7-ethyl-19-[[(2R)-2-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]acetyl]amino]-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.